Reassessing the evidence linking clinical leadership to AI deployment outcomes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 42288669.
- Also identified by DOI 10.1038/s41746-026-02911-z and PMC identifier 13264604.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Li et al. report that clinician last authorship is associated with greater "impact" in AI deployment trials. This commentary argues that current evidence is insufficient to attribute this to clinical leadership per se. Concerns include outcome definition in a literature where 88% of trials are positive, statistical instability from only 13 non-events, authorship as a noisy proxy for leadership, and structural confounding by trial design and geography.